凯镛KAIYONG品牌怎么样 申请店铺

我要投票 凯镛KAIYONG在胶原蛋白粉行业中的票数:378 更新时间:2025-08-04
凯镛KAIYONG是哪个国家的品牌?「凯镛KAIYONG」是 天津凯镛药业有限公司 旗下著名品牌。该品牌发源于天津市,由创始人曹利东在1989-09-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力凯镛KAIYONG品牌出海!将品牌入驻外推网,定制凯镛KAIYONG品牌推广信息,可以显著提高凯镛KAIYONG产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

凯镛KAIYONG怎么样

天津凯镛药业有限公司是一家坐落于天津经济技术开发区的现代化制药企业,成立于1989年,公司注册资本为人民币4000万元。

公司是专业从事药品、保健品、食品的研发、生产、销售的高科技现代化企业,企业创始人为国际中医男科学会主席、中国中医药学会男科学会会长曹开镛教授。

公司拥有口服液车间与固体制剂车间,标准净化密闭制药厂房及生化工程设备,均具备国内专业水平。公司于2003年9月份顺利通过了国家药品生产规范考核标准的GMP认证。公司现有员工近200人,其中专业技术人员26%,均具备大学水平,各职能部门分工明确。

现公司产品品种共四十余种,规格众多,其中包括以凯镛乌鸡桂圆养血口服液、凯镛小儿咳喘灵口服液为代表的OTC药品6种,更有以曹开镛男士营养液、凯镛芦荟胶囊、凯镛蛋白粉、凯镛大豆异黄酮为代表的保健食品40余种,类型包括口服液、胶囊剂、粉剂、片剂、茶剂,基本涵盖了保健品的全部种类。

天津凯镛药业有限公司与各地各级代理商及终端连锁药房合作,公司内部销售人员予以支持辅佐,共同进行销售推广,无零售业务,产品销售终端已达3000余家。整体销售团队现有近百人,分级分区管理,权责分明,覆盖面广,渠道畅通。目前公司销售市场已覆盖全国各大省市,并且获得了用户的广泛好评和信赖。

2014年7月25日,天津凯镛药业有限公司生产研发基地建设(一期)项目正式开工,整个项目总建筑面积33956.12平方米。

目前,项目主体结构已封顶,二次结构已验收合格,预计完工时间为2016年末。新厂投产后,公司的生产规模、产能将得到整体提升。


Tianjin kaiyong Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise located in Tianjin Economic and Technological Development Zone. It was founded in 1989 with a registered capital of 40 million yuan. The company is a high-tech modern enterprise specializing in the research, development, production and sales of drugs, health products and food. The founder of the company is Professor Cao kaiyong, chairman of international society of andrology of traditional Chinese medicine and President of Andrology society of Chinese medicine. The company has oral liquid workshop, solid preparation workshop, standard purification closed Pharmaceutical Workshop and biochemical engineering equipment, all with domestic professional level. In September 2003, the company successfully passed the GMP certification of the national drug production standards. The company has nearly 200 employees, including 26% of professional and technical personnel, all of whom have university level and clear division of labor in each functional department. At present, the company has more than 40 kinds of products with various specifications, including 6 OTC drugs represented by kaiyong Wuji Guiyuan blood nourishing oral liquid, kaiyong Xiaoer Kechuanling oral liquid, and more than 40 health food represented by Cao kaiyong men's nutrition liquid, kaiyong aloe capsule, kaiyong protein powder and kaiyong soybean isoflavone, including oral liquid, capsule, powder, tablet Tea agent basically covers all kinds of health products. Tianjin kaiyong Pharmaceutical Co., Ltd. cooperates with agents at all levels and terminal chain pharmacies, with the support and assistance of the company's internal sales personnel to jointly carry out sales promotion. There is no retail business, and there are more than 3000 product sales terminals. The overall sales team now has nearly 100 people, who are managed in different levels and areas, with clear rights and responsibilities, wide coverage and smooth channels. At present, the company's sales market has covered all major provinces and cities in the country, and has been widely praised and trusted by users. On July 25, 2014, the construction of production and R & D base (phase I) of Tianjin kaiyong Pharmaceutical Co., Ltd. was officially started, with a total construction area of 33956.12 square meters. At present, the main structure of the project has been capped, the secondary structure has been accepted, and the expected completion time is the end of 2016. After the new plant is put into operation, the production scale and capacity of the company will be improved as a whole.

本文链接: https://brand.waitui.com/583df2b43.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中信证券:目前重点关注的依然聚焦在AI、创新药、资源、恒科以及科创板

中信证券研报称,行情的定位决定了主导资金的行为,资金的行为决定了上涨的行业结构及模式。历史上增量流动性驱动的行情中,领涨行业大都是持续集中,而不是高切低轮动;背后的本质是资金对效率的追逐,更倾向于高共识品种,而非在低位品种里“蹲变化”。7月的行情演绎也验证了这一点,行业逐步向趋势性品种聚焦,而高切低模式效率偏低;近期增量流动性边际上有所放缓,行情需要降温才能行稳致远。目前我们重点关注的依然聚焦在AI、创新药、资源、恒科以及科创板。

58分钟前

芯导科技:拟4.03亿元购买吉瞬科技100%股权、瞬雷科技17.15%的股权 预计构成重大资产重组

8月3日,芯导科技(688230.SH)公告称,公司拟向盛锋、李晖、黄松、王青松、瞬雷优才发行可转换公司债券及支付现金,购买吉瞬科技100%股权、瞬雷科技17.15%的股权,从而直接及间接持有瞬雷科技100%股权,实现对瞬雷科技的100%控制,交易价格暂定为4.03亿元,本次交易预计构成重大资产重组。瞬雷科技主要从事功率器件的研发、生产和销售;吉瞬科技直接持有瞬雷科技82.85%的股权,仅为瞬雷科技持股主体。

58分钟前

过去七天,广东新增2892例基孔肯雅热本地病例

据广东省疾控局消息,2025年7月27日0时至8月2日24时,广东全省新增报告2892例基孔肯雅热本地病例,未报告重症和死亡病例。病例分布在佛山2770例,广州65例,东莞、中山各11例,深圳、江门、肇庆各6例,梅州5例,珠海、惠州各4例,潮州2例,阳江、云浮各1例。

58分钟前

银河证券:8月预计市场维持在震荡偏高中枢运行 关注结构性配置机会

8月3日,银河证券研报表示,近期市场行情呈现积极态势,上证指数多次创下年内新高。本轮行情受到流动性和市场预期双重驱动,融资余额自6月底以来持续上行,重返1.9万亿元上方。同时,股市上扬表现带动市场赚钱效应扩散,形成正向反馈。后续关注市场在关键点位附近的支撑力度,8月预计市场维持在震荡偏高中枢运行,关注结构性配置机会。

58分钟前

吴声“新物种爆炸2025”:AI场景革命正在让商业开启哲学生活方式周期

8月3日,“新物种爆炸·吴声商业方法发布2025”在京举行。场景实验室创始人、场景方法论提出者吴声表示:AI场景革命正在让商业开启哲学生活方式周期,关键是在每个具体场景重建意义坐标。大会还发布了新物种爆炸2025“意义重建”的八个预测,包括算法休假的AI伦理、从跨境支付到加密生活等。

58分钟前

本页详细列出关于凯镛KAIYONG的品牌信息,含品牌所属公司介绍,凯镛KAIYONG所处行业的品牌地位及优势。
咨询